4.5 Article

Copper Regulation of Hypoxia-Inducible Factor-1 Activity

期刊

MOLECULAR PHARMACOLOGY
卷 75, 期 1, 页码 174-182

出版社

AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS
DOI: 10.1124/mol.108.051516

关键词

-

资金

  1. National Institutes of Health [HL59225, HL63760]
  2. Kentucky Science and Engineering Foundation [KSEF-888-RDE-008]
  3. American Diabetes Association [7-07-JF-23]
  4. NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059225, R01HL063760] Funding Source: NIH RePORTER

向作者/读者索取更多资源

Previous studies have demonstrated that copper up-regulates hypoxia-inducible factor 1 (HIF-1). The present study was undertaken to test the hypothesis that copper is required for HIF-1 activation. Treatment of HepG2 cells with a copper chelator tetraethylenepentamine (TEPA) or short interfering RNA targeting copper chaperone for superoxide dismutase 1 (CCS) suppressed hypoxia-induced activation of HIF-1. Addition of excess copper relieved the suppression by TEPA, but not that by CCS gene silencing, indicating the requirement of copper for activation of HIF-1, which is CCS-dependent. Copper deprivation did not affect production or stability of HIF-1 alpha but reduced HIF-1 alpha binding to the hypoxia-responsive element (HRE) of target genes and to p300, a component of HIF-1 transcriptional complex. Copper probably inhibits the factor inhibiting HIF-1 to ensure the formation of HIF-1 transcriptional complex. This study thus defines that copper is required for HIF-1 activation through the regulation of HIF-1 alpha binding to the HRE and the formation of the HIF-1 transcriptional complex.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据